Catalent Experts to Present Use of Practical Aspects of New Technologies at Upcoming Bioassay Conference

Somerset, N.J. (PRWEB) March 20, 2015 Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Dr. Mike Sadick, Senior Manager, Large Molecule Analytical Chemistry, and Dr. Tom Luntz, Group Leader, Cell Based Assays, will both speak at the upcoming CASSS ...

Catalent Announces New Organization To Speed New Products To Market

Catalent Announces New Organization To Speed New Products To Market
Somerset, N.J. (PRWEB) March 16, 2015 Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has today announced that Sharon Johnson, Senior Vice President, Global Quality & Regulatory Affairs, is to head up Catalent’s newly formed Quality, Product Development & Regulatory Affairs organization, ...

Catalent and SELLAS Sign Exclusive Agreement for Therapeutic Reprofiling of Zolpidem

Somerset, N.J. (PRWEB) December 04, 2014 Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it had reached an exclusive development and licensing agreement with Swiss-based development-stage biopharmaceutical company SELLAS Life Sciences Group (SELLAS), to support the development and therapeutic ...

Catalent and Valerion Therapeutics Collaborate to Bring New Treatments for Orphan Genetic Disorders to Market

Somerset, N.J. (PRWEB) December 02, 2014 Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is to collaborate with Valerion Therapeutics, LLC, an emerging science-driven company, focused on the development of bio-therapeutics for orphan genetic diseases, to develop Valerion’s ...